ZPHC

Cabergoline ZPHC — 0.25 mg × 50 tablets

Name: Cabergoline ZPHC — 0.25 mg × 50 tablets
Brand: ZPHC

0 opiniones de clientes

Precio bajo consulta

Cabergoline — prolactin-control research compound 50 film-coated tablets × 0.25 mg Main function: lowers serum prolactin by activating pituitary D₂ receptors, keeping levels in the low-normal range. When it’s used: Trenbolone / Nandrolone studies, hyper-prolactinaemia models, libido or erectile-function research. Typical research dosing: 0.25 mg twice weekly (bloodwork-guided ceiling ≈ 1 mg / week). Expected benefits: prevents gynecomastia, water retention, mood swings, low libido and “tren coug

● Agotado

Referencia: cabergoline-zphc-0-25-mg-50-tablets-default
Marca: ZPHC
Categoría: Post Cycle Therapy (PCT), Esteroides orales, Cabergoline

Cabergoline ZPHC is a dopamine agonist formulated for precise prolactin control, supplied as 50 film-coated tablets of 0.25 mg pharmaceutical-grade Cabergoline.

Its main function is lowering serum prolactin by activating pituitary D2 receptors, keeping levels in the low-normal range. It is most often used alongside Trenbolone or Nandrolone-based cycles, in hyperprolactinaemia management, and in libido or erectile-function support, preventing gynecomastia, water retention, mood swings, low libido and "tren cough" associated with elevated prolactin.

Key Benefits

Precisely controls serum prolactin via D2 receptor activation
Prevents gynecomastia and water retention linked to high prolactin
Supports healthy libido and erectile function
Reduces mood swings and "tren cough" symptoms
Manufactured to strict QC standards (≥ 99% API purity, HPLC-verified, GMP tablet press, tamper-evident packaging)